English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Prescription of medicines for use under conditions other than authorized, colloquially known as “off-label” prescription, is a common practice in child and adolescent psychiatry. This practice has clinical and legal consequences for both the patient and the prescriber, so it is important to have up-to-date information on the approved indications and the legal status derived from this type of prescription. This article carries out a comprehensive and up-to-date review of the specific indications for children and adolescents of 112 drugs used in psychiatry, according to the information contained in the 177 corresponding “summary of product information” approved for marketing in Spain. Off-label prescription Central Nervous System drugs in children under 18 years of age is the rule rather than the exception and therefore systematically would require obtaining informed consent, according to the current normative.

revista de psiquiatría infanto-juvenil/revista de psiquiatría infanto-juvenil

Las indicaciones conforme a ficha técnica de los psicofármacos prescritos en psiquiatría del niño y del adolescente. Revisión, actualización, uso “fuera de ficha” y consideraciones legales